Enterococcal Infections in Left Ventricular Assist Device Recipients: Two Clinical Cases and Systematic Review
Authors:
- Cristina GayCGCristina Gay
- Lucía Ramos-MerinoLRLucía Ramos-Merino
- Elena SandovalESElena Sandoval
- David Couto-MallónDCDavid Couto-Mallón
- Andrés PerissinottiAPAndrés Perissinotti
- María García-VieitesMGMaría García-Vieites
- Eduardo Barge-CaballeroEBEduardo Barge-Caballero
- Marta FarreroMFMarta Farrero
- Marta Hernández-MenesesMHMarta Hernández-Meneses
- María G. Crespo-LerioMCMaría G. Crespo-Lerio
Open Access
Abstract
Background: Infections remain a major complication in patients with left ventricular assist devices (LVADs). Enterococcal infections are increasingly recognized and are therapeutically challenging because of antimicrobial tolerance, biofilm formation on prosthetic material, and the frequent impossibility of device removal. Objective and method: We report two clinical cases of Enterococcus faecalis LVAD infection and a PRISMA-based systematic review of cases published between 1996 and 2025 that were identified through PubMed/MEDLINE. Primary outcomes were clinical cure, relapse or recurrence, mortality, and device removal. Results were synthesized descriptively. Results: Seventeen cases were analyzed, including 15 previously reported cases and two new cases. E. faecalis accounted for 47% of infections, Enterococcus faecium for 29%, and Enterococcus spp. without species identification for 24%. Bacteremia was the most common presentation, occurring in 76%, whereas LVAD-associated endocarditis occurred in 18%. Driveline or pocket involvement was reported in 41%. Suppressive antimicrobial therapy (SAT) was used in 29%, often as a bridge to heart transplantation. Cultures from explanted LVAD components were positive in 47% of cases despite prolonged antimicrobial therapy. Recurrence or relapse and overall mortality each occurred in 18% of patients. Conclusions: Enterococcal LVAD infections may be associated with microbiological persistence despite prolonged therapy. SAT may help control infection in selected patients and bridge to heart transplantation when device removal is not feasible.Keywords
Funding Information
- Instituto de Salud Carlos III (J23/00035)
- European Commission
This publication has 38 references indexed in Scilit:
- The International Society for Heart and Lung Transplantation (ISHLT): 2024 infection definitions for durable and acute mechanical circulatory support devicesThe Journal of Heart and Lung Transplantation, 2024
- The 2023 International Society for Heart and Lung Transplantation Guidelines for Mechanical Circulatory Support: A 10- Year UpdateThe Journal of Heart and Lung Transplantation, 2023
- Dalbavancin as long-term suppressive therapy for patients with Gram-positive bacteremia due to an intravascular source—a series of four casesInfection, 2020
- The value of 18F-FDG PET/CT for the diagnosis of device-related infections in patients with a left ventricular assist device: a systematic review and meta-analysisEuropean Journal of Nuclear Medicine and Molecular Imaging, 2020
- Lead Extraction for Cardiovascular Implantable Electronic Device Infection in Patients With Left Ventricular Assist DevicesJACC: Clinical Electrophysiology, 2020
- A Contemporary Picture of Enterococcal EndocarditisJACC, 2020
- Epidemiology of infection in mechanical circulatory support: A global analysis from the ISHLT Mechanically Assisted Circulatory Support RegistryThe Journal of Heart and Lung Transplantation, 2019
- The role of FDG PET/CT in therapy control of aortic graft infectionEuropean Journal of Nuclear Medicine and Molecular Imaging, 2018
- Real-Time Autofluorescence Imaging to Diagnose LVAD Driveline InfectionsThe Annals of Thoracic Surgery, 2017
- Implantable LVAD infections: Implications for permanent use of the deviceThe Annals of Thoracic Surgery, 1996